Senior Research Associate, Bioconjugation (South San Francisco, CA)

Sutro Biopharma, Inc. is seeking a highly motivated Senior Research Associate with background in bioconjugation and analytics to join our Protein Biochemistry Group. The successful candidate will have a key role on cross functional teams to advance protein therapeutics, including but not limited to antibody drug conjugates, PEGylated protein, protein-protein conjugates, and protein-nucleotide conjugates. The critical role will contribute to the optimization and development of bioconjugation techniques as well as characterization of conjugates. 

Responsibilities

  • Synthesis, characterization, and delivery (in a timely manner) of protein conjugates in support of discovery and development of novel protein therapeutics.
  • Development of bioconjugation and characterization methods to generate novel bioconjugates.
  • Execution of protein analytical methods to characterize protein and bioconjugates using HPLC, LC-MS, UV-vis, gel-electrophoresis, and DLS.

Qualifications

  • BS in chemical biology, biochemistry, chemistry, molecular biology, or a related field with 1-3 years of experience; MS in chemical biology, biochemistry, chemistry, molecular biology, or a related field with 0 to 2 years of experience.
  • Experience in characterization of proteins and protein conjugates using applicable techniques. Comfortable with routine use of HLPC (RP-, HIC-, SEC-, and CIEX-).
  • Hands on experience in LCMS is a plus, but not required.
  • Experience working with protein through expression, purification, or characterization.
  • Demonstrated ability to work independently, learn and optimize new conjugation techniques and protein analytical methods.
  • Thorough understanding of protein expression, purification, and characterization.
  • Ability to prioritize work assignment, and consistently perform assigned tasks.

Sound exciting? Apply today and join our team! 

Please submit resume for Req. #2264 to jobs@sutrobio.com. Please visit our website at www.sutrobio.com for more information.

Sutro provides a competitive benefits package that includes a choice of health, dental, and vision insurance, life insurance, flexible spending accounts, 401K plan, PTO, ESPP (Employee Stock Purchase Plan) and stock options.

As an equal opportunity employer, we believe in fostering a culture that is inclusive and values diversity in background and opinions. Sutro Biopharma hires extraordinary individuals into every position in the company and is committed to the diversity of our team. Our company progresses without regard of race, ethnicity, gender, sexual orientation, religious belief, age, disability or citizenship status. We are dedicated to creating a safe environment where our employees can grow and succeed together. 

Salaries listed on jobsites may not be representative of salary ranges at Sutro Biopharma.

Please be advised, inquiries or resumes from recruiters will not be accepted.

Company Overview 

Sutro Biopharma, Inc., located in South San Francisco, is a clinical-stage drug discovery, development and manufacturing company. Using precise protein engineering and rational design, Sutro is advancing next-generation oncology therapeutics.

Sutro is dedicated to transforming the lives of cancer patients by creating medicines with improved therapeutic profiles for areas of unmet need. To date, Sutro’s platform has led to cytokine-based immuno-oncology therapies, ADCs, vaccines and bispecific antibodies directed at precedented targets in clinical indications where the current standard of care is suboptimal.

The platform allows it to accelerate discovery and development of potential first-in-class and best-in-class molecules through rapid and systematic evaluation of protein structure-activity relationships to create optimized homogeneous product candidates.

In addition to developing its own oncology pipeline, Sutro is collaborating with select pharmaceutical and biotech companies to discover and develop novel, next-generation therapeutics. As the pace of clinical development accelerates, Sutro and its partners are developing therapeutics designed to more efficiently kill tumors without harming healthy cells.